Last reviewed · How we verify

NCT03744936: (DA4AFib)

Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)

Completed Results posted Last updated 24 January 2025
What this trial tests

trial testing Feedback in Atrial Fibrillation in 34 participants. Completed in 6 February 2020.

Timeline
4 October 2018
Primary endpoint
6 February 2020
6 February 2020

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date4 October 2018
Primary completion6 February 2020
Estimated completion6 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Interview Process Primary · baseline

The number of subjects to complete the interview process

GroupValue95% CI
Nonvalvular Chronic Atrial Fibrillation (DA4AFib)34

Sponsor's own description

The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Feedback

Trials testing the same drug.

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing